<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04673721</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00105996</org_study_id>
    <nct_id>NCT04673721</nct_id>
  </id_info>
  <brief_title>PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health</brief_title>
  <acronym>PROSPERITY</acronym>
  <official_title>PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eggland's Best, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to assess the effect of fortified eggs (compared to a non-egg&#xD;
      supplemented diet) and intermittent fasting (IF) (compared to a usual care diet) on biomarker&#xD;
      profile at 4 months. This will be a 140-participant, 2x2 factorial, randomized clinical trial&#xD;
      comparing fortified eggs vs. a non-egg supplemented diet and IF vs. usual care diet through 4&#xD;
      months. Participants will be randomized 1:1:1:1 to the four treatment groups. Participants&#xD;
      will have in-person follow-up visits at 1- and 4- months (inclusive of laboratory&#xD;
      assessments) in addition to telephone calls at months 2 and 3. A subset of patients (~24 in&#xD;
      each egg randomized strata) will undergo microbiome assessment at baseline and at 4 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in LDL-cholesterol</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in HDL-cholesterol</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in total cholesterol</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in triglycerides</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NMP LipoProfile</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lipoprotein subfractionation</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in apolipoprotein B</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fatty acid profile</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin B2 level</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin B12 level</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin D level</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin E level</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in selenium level</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in high-sensitivity troponin (hsTroponin)</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in high-sensitivity c-reactive protein (hsCRP)</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hemoglobin A1c (HbA1c)</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin resistance score (LP-IR)</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in weight</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>Baseline, 4 months</time_frame>
    <description>Both systolic and diastolic blood pressure will be assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Dietary intake (2005-Block Questionnaire)</measure>
    <time_frame>Baseline, 4 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in microbiome profile</measure>
    <time_frame>Baseline through 4 months</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Hypercholesterolemia</condition>
  <condition>Hyperlipidemia</condition>
  <condition>Vitamin Deficiency</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Fortified eggs + Intermittent fasting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Consume at least 12 fortified eggs per week with 16-hour fast and then an 8-hour nutritional window.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-egg supplemented diet + Intermittent fasting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Maintain consumption of 2 or less eggs per week with 16-hour fast and then an 8-hour nutritional window.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fortified eggs + Usual care diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Consume at least 12 fortified eggs per week with consistency with current diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-egg supplemented diet + Usual care diet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maintain consumption of 2 or less eggs per week with consistency with current diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fortified eggs</intervention_name>
    <description>Average 12 eggs consumed per week</description>
    <arm_group_label>Fortified eggs + Intermittent fasting</arm_group_label>
    <arm_group_label>Fortified eggs + Usual care diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intermittent fasting</intervention_name>
    <description>16-hour fast and then an 8-hour nutritional window with aim for energy needs to be consumed during an 8 hour eating window (e.g., 11 am - 7 pm) with fasting for 16 hours (e.g., 7 pm - 11 am the next day).</description>
    <arm_group_label>Fortified eggs + Intermittent fasting</arm_group_label>
    <arm_group_label>Non-egg supplemented diet + Intermittent fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Non-egg supplemented</intervention_name>
    <description>2 or less eggs consumed per week</description>
    <arm_group_label>Non-egg supplemented diet + Intermittent fasting</arm_group_label>
    <arm_group_label>Non-egg supplemented diet + Usual care diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual care diet</intervention_name>
    <description>Consistency with current diet without consideration of intermittent fasting</description>
    <arm_group_label>Fortified eggs + Usual care diet</arm_group_label>
    <arm_group_label>Non-egg supplemented diet + Usual care diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 50 years of age AND&#xD;
&#xD;
          -  At least one of the following two criteria:&#xD;
&#xD;
               -  Prior cardiovascular event (myocardial infarction, coronary revascularization or&#xD;
                  ischemic stroke) OR&#xD;
&#xD;
               -  2 cardiovascular risk factors including: 1) Diabetes mellitus (Defined as taking&#xD;
                  a medication for diabetes OR HgbA1c ≥6.5% within the prior 18 months; patients&#xD;
                  with diabetes may be treated with medications that are not associated with&#xD;
                  hypoglycemia such as metformin, thiazolidinediones (TZDs), glucagon-like&#xD;
                  peptide-1 receptor agonists (GLP-1 RAs), sodium glucose co-transporter 2 (SGLT2)&#xD;
                  inhibitors and/or dipeptidyl peptidase-4 (DPP-4) inhibitors, 2) Body mass index&#xD;
                  (BMI) ≥ 30 kg/m2, 3) Hypertension (Defined as taking blood pressure lowering&#xD;
                  medications OR systolic BP &gt; 140mmHg at screening OR diastolic BP &gt; 90mmHg at&#xD;
                  screening), 4) Dyslipidemia (Defined as taking lipid lowering medication OR LDL&#xD;
                  ≥130 OR HDL &lt;50 for women OR HDL &lt;40 for men OR triglycerides ≥150), or 5)&#xD;
                  Chronic kidney disease (Defined as eGFR &lt;60 on most recent laboratory assessment&#xD;
                  within prior 18 months)&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known allergy or intolerance to eggs&#xD;
&#xD;
          -  Patients with diabetes who are on insulin or insulin secretagogues (e.g.,&#xD;
             sulfonylureas and meglitinides)&#xD;
&#xD;
          -  Recent cardiovascular event (MI, stroke, HF hospitalization) within the past 30 days&#xD;
&#xD;
          -  Planned initiation/change in lipid therapy within the next 4 months&#xD;
&#xD;
          -  Current daily use of any supplements or multivitamins containing Vitamin B2&#xD;
             (riboflavin), Vitamin B12, Vitamin D, Vitamin E, or selenium or planned initiation&#xD;
             within the next 4 months (current users need a 1-month washout period off supplement&#xD;
             prior to eligibility)&#xD;
&#xD;
          -  Inability or unwillingness to comply with the study requirements&#xD;
&#xD;
          -  History of heart transplant or left ventricular assist device&#xD;
&#xD;
          -  Pregnant or nursing women&#xD;
&#xD;
          -  Malignancy or other non-cardiac condition limiting life expectancy to &lt;4 months&#xD;
&#xD;
          -  Consumption of &gt; 2 eggs per week (this does not include eggs contained within other&#xD;
             foods)&#xD;
&#xD;
          -  Ongoing or recent (prior 30 days) participation in another interventional study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Mentz, MD, FACC, FAHA, FHFSA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Cardiovascular Disease Fellowship</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Ashworth, CRC</last_name>
    <phone>919-681-3610</phone>
    <email>jessica.ashworth@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Ashworth, CRC</last_name>
      <phone>919-681-3610</phone>
      <email>jessica.ashworth@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Mentz, MD, FACC, FAHA, FHFSA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neha Pagidipati, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fortified eggs</keyword>
  <keyword>High cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Avitaminosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

